The association between peak systolic blood pressure (SBP) during exercise testing and outcome remains controversial, possibly due to the confounding effect of external workload (METs) on peak SBP as well as on survival. Indexing the increase in SBP to the increase in workload (SBP/MET-slope) could provide a more clinically relevant measure of the SBP response to exercise. We aimed to characterize the SBP/MET-slope in a large cohort referred for clinical exercise testing and to determine its relation to all-cause mortality.
INTRODUCTION
Blood pressure (BP) is routinely assessed and reported as an integral part of clinical exercise testing. 1 Current scientific statements and guidelines by the American Heart Association (AHA) 1 and the American College of Sports Medicine (ACSM) 2 , define an exaggerated systolic BP (SBP) response to exercise as a peak SBP of ≥210 mmHg in males and ≥190 mmHg in females.
These thresholds approximate the 90th percentile in young, healthy subjects, [3] [4] [5] but are not consistently associated with outcome. In fact, systematic reviews and meta-analyses [6] [7] [8] suggest a complex and somewhat ambiguous association between the SBP response to exercise and mortality. In some populations, a high peak SBP has been related to a lower risk of future cardiovascular events and all-cause mortality. [9] [10] [11] [12] Using absolute thresholds for SBP response to exercise is problematic due to the linear relationship between SBP (via cardiac output) and external workload, [13] [14] [15] as higher achieved workloads implies higher level of fitness; in turn strongly associated with survival. 16, 17 Reporting SBP in relation to workload could account for this relationship and therefore provide a more robust and physiologically relevant measure than absolute peak SBP. Guidelines on exercise testing provide an estimated normative increase in SBP of ~10 mmHg/metabolic equivalent of task (MET), 1, 2 although this suggested value of the SBP/MET-slope was recently challenged. 18 To our knowledge, the SBP/MET-slope has never been evaluated in a large clinical population, and its prognostic value is unknown.
The purpose of this study was to characterize the SBP/MET-slope, as a measure of workload-indexed SBP response to exercise, in a large clinical population of males referred for exercise testing and to determine its association with all-cause mortality.
METHODS

Study Design and Sample
The Veterans Exercise Testing Study is an ongoing, prospective evaluation of US-Veterans referred for exercise testing, designed to address exercise test, clinical and lifestyle factors and their associations to health outcomes. The study was approved by the Institutional Review Board at Stanford University, and all subjects gave written informed consent prior to undergoing the baseline examination. Male Veterans who underwent a treadmill exercise test at the Veterans Affairs Health Care System in Palo Alto, California between 1987 and 2007 were considered for inclusion (n=9079). Exclusion criteria are detailed in figure 1a.
Demographic, clinical, and medication information was obtained from each subject's computerized medical records just prior to the exercise test. This included information on previous cardiovascular and pulmonary disease, hypertension, hypercholesterolemia, diabetes mellitus, smoking status (current and past), and use of cardiac medications and family history of coronary disease. For details on the definitions used, see Supplementary material online, methods 1.1. and Table S1 .
We ascertained vital status of the participants as of July 20, 2018. We verified dates of death using the VA Beneficiary Identification and Record Locator System File, which has been estimated to be 95% complete and accurate. 19 Follow-up time was the time from the exercise test to death or to the date when a subject was last verified to be alive.
Exercise Assessments
Each subject underwent a standardized treadmill exercise test, using an individualized ramp protocol. Standard criteria for termination were used, including signs of inducible cardiac ischemia or a sustained drop in SBP. 1,2 A SBP >250 mmHg or a diastolic BP >115 mmHg were relative indications for test termination. 1, 2 Peak exercise capacity in METs was estimated automatically using standard ACSM equations. 2 Age-predicted peak METs was calculated using a population-specific equation as: 18 -[0.15 × Age]. 20 Blood pressure was measured by auscultation, standing at rest before the exercise test (SBPrest) and just prior to test termination (SBPpeak). The ΔSBP was calculated as (SBPpeak -SBPrest) and indexed by the increase in METs from rest (ΔMETs; [peak METs -1]) to obtain the SBP/MET-slope. For details on the exercise test measurements and calculations, see
Supplementary material online, methods 1.2.
Subgroups and Categories
Lower risk group
To explore the effect of comorbidities and risk factors on the SBP/MET-slope and to obtain 50th, 90th and 95th percentiles, we defined a subgroup of patients with lower cardiovascular risk. This group included non-smoking subjects surviving at least ten years following the exercise test, without a history of diabetes mellitus, hypertension or cardiovascular disease. A detailed description of the selection of lower risk subjects is presented in Supplementary material online, methods 1.3.
SBP/MET-slope versus peak MET categories
To determine the effect of the SBP/MET-slope on mortality in subjects with higher versus lower fitness, we defined four groups based on the median value of peak METs and of the SBP/MET-slope of the main sample: 1) higher MET/lower slope; 2) higher MET/higher slope;
3) lower MET/lower slope and 4) lower MET/higher slope.
Hypotensive blood pressure response group
Subjects with a ΔSBP ≤0 mmHg or an exercise test terminated due to a sustained drop in SBP were not included in the main sample, but analyzed separately in the outcome analysis.
Statistical Analysis
SPSS software, v25.0 (IBM Corp, Armonk, NY, USA) was used for database management and statistical analysis. Survival analyses were performed using R Studio v1.1.456 (R Studio Inc., Vienna, Austria) with the survival (v2.38) and survminer (v0.4.3) packages. Continuous variables were presented as mean (standard deviation, SD) or median (interquartile range, IQR) based on their distribution. We compared means, medians and proportions using Student's ttests, Mann-Whitney U-tests and 2 tests, respectively. Two-sided statistical significance was set at <0.05.
All outcome analyses were performed with 20-years all-cause mortality as endpoint. We applied the Kaplan-Meier method according to quartiles of the hemodynamic variables of interest, comparing survival over time using the log-rank (Mantel-Cox) test. Unadjusted and adjusted Cox proportional hazard ratios (HR) were calculated for quartiles of hemodynamic variables as well as for standardized continuous variables (Z-scores). Logistic regression was used to determine predicted probability of death within 20 years. The covariables included in the adjusted Cox models are detailed in Supplementary material online, methods 1.4. Several sensitivity analyses were performed excluding subjects on cardiac medications and/or different combinations of cardiovascular diseases. A landmark analysis set to year 1997 was performed to explore the stability over time in survival based on SBP/MET-slope.
RESULTS
Study population characteristics
A total of 7298 males (mean age 58.6±11.0 years; 5 th -95 th percentiles 40.6-76.3 years) were included in the main sample, of which 709 subjects were defined as having lower cardiovascular risk (table 1). In addition, 244 subjects with a drop or no increase in SBP during exercise (∆SBP ≤0 mmHg) were included for separate analysis. This group presented with a considerably higher prevalence of previous CAD (47.5% vs. 22.5%, p<0.001) than other subjects. The risk factor profile and prevalence of comorbidities at the time of inclusion changed over the study enrollment period (figure 1b-c). The unadjusted and adjusted relative risks of mortality associated with comorbidities, risk factors and use of medication are presented in Supplementary material online table S2.
Hemodynamic data
In total, 1152 (15.8%) subjects had an exaggerated SBP response to exercise as defined by the guidelines (i.e. peak SBP ≥210 mmHg). This group achieved higher absolute peak METs (as absolute and percentage of age-predicted), a higher rate of perceived exertion and a higher peak heart rate than those with peak SBP <210 mmHg (Supplementary material online table S3 ). In addition, these subjects presented with higher systolic and diastolic BP at rest (148±19 vs.
129±17 and 88±11 vs. 80±11 mmHg, both p<0.001) and lower prevalence of previous CAD than subjects with peak SBP <210 mmHg.
Peak METs correlated weakly with SBP at rest (r=-0.12, p<0.001) and with peak SBP (r=0.16, p<0.001) and slightly stronger with ∆SBP (r=0.29, p<0.001). The SBP/MET-slope showed a moderate negative correlation with peak METs (r=-0.50, p<0.001), but this association was weaker in subjects within the middle two quartiles of fitness (i.e. 6.2-10.9 METs,
Supplementary material online table S4
and Supplementary material online figure S1). 
Systolic blood pressure at rest and peak exercise and mortality
There was an increased risk of mortality for subjects in the two upper quartiles of SBP at rest (i.e. >130 mmHg) in unadjusted analysis, but no difference between quartiles in fully adjusted analysis (Supplementary material online figure S2). For peak SBP, subjects with lower peak SBP had greater risk of 20-year mortality during follow-up in both unadjusted and adjusted analyses (Figure 1) . The HRs for each hemodynamic variable standardized as Z-score is presented in Supplementary material online table S6.
An excessive SBP response to exercise as defined by the guidelines (i.e. peak SBP ≥210 mmHg) was not related to increased mortality in unadjusted analysis (HR 0.92, 95% CI 0.83-1.01, p=0.07). When considering other risk factors, subjects without an excessive SBP response to exercise (i.e. peak SBP <210 mmHg) had 20% higher relative risk of mortality (fully adjusted HR: 1.20, 95% CI 1.08-1.32, p<0.001) vs. subjects with peak SBP ≥210 mmHg. After excluding subjects with atrial fibrillation or previous CAD, stroke, claudication in a sensitivity analysis, the fully adjusted HR associated with a peak SBP <210 mmHg was 1.17 (95% CI 1.04-1.32, p=0.010).
Subjects with a drop or no increase in SBP with exercise had a 88% (HR 1.88, 95% CI 1.61-2.20, p<0.001) higher unadjusted risk of all-cause mortality as compared to those with ∆SBP >0 mmHg. After adjusting for comorbidities, risk factors and beta-blockers, there was a statistically non-significant 12% increase in risk associated with a drop or no increase in SBP (HR 1.12, 95% CI 0.95-1.32, p=0.17).
SBP/MET-slope and mortality
Subjects with higher SBP/MET-slope had greater cumulative risk of mortality during follow-up (Figure 3) . In the highest quartile of the SBP/MET-slope (i.e. >9 mmHg/MET), 1028 subjects (57%) died during 20 years of follow-up, compared to 703 subjects (37%) in the lowest quartile (i.e. ≤4.3 mmHg/MET). After adjusting for age, test year, body mass index and cardiovascular risk factors, medications and comorbidities, subjects with an SBP/MET-slope in the highest quartile had a 23% (HR 1.23, 95% CI 1.12-1.36) higher risk of mortality than subjects in the lowest quartile. Excluding subjects with β-blockers, anti-hypertensive medication, previous cardiovascular comorbidities or atrial fibrillation did not substantially alter these findings (sensitivity analyses; Supplementary material online table S7 and S8). Subjects with an SBP/MET-slope >10 mmHg/MET (95 th percentile in lower risk group and by guidelines suggested normal, average increase) had a 69% (HR 1.69, 95% CI 1.56-1.84) and 20% (HR 1.20, 95% CI 1.10-1.31) higher risk of all-cause mortality vs. those with ≤10 mmHg/MET in the unadjusted and fully adjusted model, respectively. The relationship between SBP/MET-slope and mortality had a J-shape, with the lowest mortality for those with a slope around 4 mmHg/MET (Supplementary material online Figure S4 ). In a landmark analysis, overall survival increased by two years from the first to the second period of inclusion (landmark year 1997), but the prognostic pattern of SBP/MET-slope persisted (Supplemental material online Figure S4 ). 
Fitness, SBP/MET-slope and mortality
DISCUSSION
This study demonstrated in a large cohort of male Veterans that higher workload-indexed SBP response to exercise rather than higher peak SBP was predictive of all-cause mortality. We also observed that in a subset of lower risk subkects, a 10 mmHg increase in SBP per MET corresponded to the upper 95th percentile rather than an average value as proposed by current exercise testing guidelines.
Reappraisal of the normal SBP response to exercise.
During lower-or whole-body exercise, external workload is closely related to cardiac output and SBP, confirmed by early invasive studies. 13, 15, 21 Accordingly, in male athletes reaching maximal effort, 22 upper limits of normality in peak exercise SBP have been reported to be higher than in the general population. 3, 5 However, the normal workload-indexed response in SBP with exercise is not well defined. 18 Although current guidelines on exercise testing suggest that SBP increases on average by 10 mmHg/MET during graded exercise, 1,2 the underlying evidence is equivocal, and was recently questioned. 18 In a subgroup of 713 subjects with lower cardiovascular risk and surviving at least 10 years from baseline, we observed 5 mmHg/MET and 10 mmHg/MET to represent the 50th and 95th percentile respectively. Notably, we also observed a median SBP/MET-slope of 6.3 mmHg/MET in the remaining 6602 subjects with higher baseline risk.
Our data suggest that the proposed normal increase in SBP per MET of 10 mmHg/MET 1,2 represent an upper limit rather than an average expected increase.
Peak SBP and mortality.
The definition and consequence of an exaggerated BP response with exercise remain controversial, 4, 18, 23 and is more consistently reported as predictive of future development of hypertension 7,24-27 than of cardiovascular risk and future mortality. 6, 11, 28 Comparison across studies is challenging, considering the inconsistencies which exist in definitions and terminology for BP response to exercise. 1, [29] [30] [31] . In addition, SBP determined at a submaximal 24, 28 or at peak external workload 11, 25, 26 have been used to define thresholds. We found the adjusted relative risk of all-cause mortality to be 20% greater in subjects who did not reach a peak SBP ≥210 mmHg during exercise. This risk was still 16% higher after excluding subjects with known baseline cardiovascular disease. However, it is possible that a significant proportion of subjects had undiagnosed, subclinical cardiovascular disease which could manifest itself as an inability to adequately increase SBP during exercise. Nevertheless, our data suggest that in a clinical referral sample, reaching the threshold defined as an exaggerated SBP response per current guidelines, is not necessarily associated with increased risk of mortality in males.
One important factor to consider when reviewing previous literature on the SBP response to exercise and its association with outcomes is the baseline risk factor profile of the population being studied. In a study on 4907 males free from known heart disease and with a negative exercise ECG, Filipovský et al. (1992) found an increased relative risk of all-cause and cardiovascular mortality with higher ΔSBP during bicycle exercise testing. 32 Similarly, in a highly selected sample of 300 normotensive, asymptomatic subjects undergoing clinical treadmill testing at the Mayo Clinic, the adjusted odds ratio for a major cardiovascular event within 7.7±2.9 years of testing was 3.62 (p=0.03) in subjects with a peak exercise SBP of ≥214 mmHg (n=150), compared to those with a peak SBP of 170-192 mmHg (n=150). 30 In contrast, studies including subjects with verified or high risk of CAD have shown better 9 or similar 12 survival in subjects reaching a peak SBP ≥210 mmHg than in subjects with lower peak SBP.
Moreover, Hedberg et al. (2009) showed that in 372 community-dwelling 75-year old subjects, those with the highest ΔSBP at the baseline exercise test (≥55 mmHg) had the lowest risk of allcause and cardiovascular mortality during an average follow-up time of 10.6 years. 10 In the current study, 23% of the sample had a history of CAD while 2.8% and 3.7% had a previous diagnosis of stroke or claudication, respectively. Notably, the proportion of subjects with known CAD referred for exercise testing declined from ~40% during the early years of study inclusion (1987) (1988) to ~10% around the year 2000 (figure 1). However, after excluding subjects with previous cardiovascular disease, the relationships between low ΔSBP or a high SBP/MET-slope and mortality persisted.
The impact and rationale of considering external workload for risk prediction.
In contrast to the lower mortality associated with a higher peak SBP or ΔSBP in our subjects, indexing the increase in SBP to external workload revealed an inverse relationship as a greater SBP/MET-slope was associated with higher mortality. Having an SBP/MET-slope over 10 mmHg/MET was associated with 69% and 20% higher risk of 20-year all-cause mortality in unadjusted and adjusted analyses, respectively. Given the strong association between fitness and survival, 1, 16, 17 and the near linear relationship between external workload and SBP, [13] [14] [15] this is somewhat expected. In fact, studies measuring SBP at a defined submaximal workload have shown an association between submaximal SBP measures and mortality, 28,33 as well as with incident myocardial infarction, 34 and stroke. 35 Using a meta-analytic approach, Schultz and coworkers (2013) showed that SBP at a submaximal intensity significantly increased the risk of experiencing a composite of cardiovascular event and/or death by 4% per 10 mmHg, while SBP at peak exercise was not associated with higher risk. 6 Thus, relating exercise SBP to workload, either as SBP measured at a defined submaximal workload or as the SBP/MET-slope as in our study, seems superior in terms of prognostic capability. The SBP/MET-slope offers a method more applicable to ramp protocols, where precise measures at a specified submaximal workload may be difficult to accurately obtain.
The current study also underscores the strong relationship between fitness and survival, 1, 16, 17 as peak METs was a strong determinant of survival, and adjusting for peak METs in the continuous analysis of Z-scores rendered most HRs non-significant. However, the SBP/MET-slope to add precision in terms of predicting survival in subjects with higher fitness.
Specifically, in subjects achieving a peak METs value ≥8.2 (the median in the main sample), having an SBP/MET-slope ≥6.2 was associated with 27% higher adjusted risk of all-cause mortality.
Limitations
First, our subjects were recruited as a clinically referred cohort and were all male; thus, these results are not necessarily representative of a general population or females. Second, measures of cardiac output and oxygen uptake were unavailable, and we relied on estimated external workload (METs) from standard, validated ACSM formulas. 2 Third, submaximal measures of SBP were unavailable, and could have provided additional insight to the SBP response to exercise. Finally, we only had data on all-cause mortality, and our results calls for studies exploring the association between SBP/MET-slope and cardiovascular end-points.
Conclusions
Subjects exceeding the threshold defined as an exaggerated SBP response to exercise had better survival, while higher SBP/MET-slope was associated with worse survival. The SBP/MET-slope may add prognostic precision, at least among subjects with higher fitness, and could be considered for integration into clinical exercise testing reports. 
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Definitions of cardiovascular comorbidities and risk factors
We used the following definitions in determining the presence of cardiovascular comorbidities and risk factors at baseline exercise testing:
• Previous coronary artery disease (CAD); previous myocardial infarction, cardiac procedures/interventions and/or coronary artery stenosis >50% at imaging.
• Atrial fibrillation; atrial fibrillation registered on ECG at rest or during exercise at time of exercise testing.
• Previous stroke, claudication or chronic obstructive pulmonary disease (COPD); a diagnosis at time of test as per medical records.
• Family history of CAD; an immediate family member having ischemic heart disease before the age of 60.
• Hypertension; previous diagnosis of hypertension and/or use of any anti-hypertensive medication (not including beta-blockers).
• Smoking; Current smoker or previous smoker with history of >10 pack-years of smoking.
• Hypercholesterolemia; Total cholesterol >220 mg/dL, statin use, or both.
• Diabetes; a diagnosis at time of test per medical records.
• Cardiac medications; use of any of the following as per medical records, and verified at time of test: statins, anti-hypertensives (incl. angiotensine converting enzyme-inhibitors, angiotensine receptor antagonists, calcium channel blockers), Aspirin and Beta-blocker.
Details on exercise testing and exercise capacity estimation
Each subject underwent a standardized treadmill exercise test using an individualized ramp protocol. The choice of protocol was individualized based on estimated exercise capacity and a targeted 8-12 min exercise duration, using the one-page Veterans Specific Activity Questionnaire. Subjects were encouraged to exercise without handrail support until volitional fatigue in absence of any indication for stopping the test (see below). Age-predicted maximal heart rate was not used as a target endpoint. The degree of effort was quantified using the Borg scale of perceived exertion.
Standard criteria for termination were used, including signs of inducible cardiac ischemia (i.e >2.0 mm horizontal/downsloping ST depression, moderately severe angina, a sustained drop in systolic blood pressure (SBP) or serious rhythm disturbances). A SBP >250 mmHg or a diastolic BP >115 mmHg were relative indications for test termination.
Peak exercise capacity was estimated as metabolic equivalents of task (METs), which is a surrogate measure of peak oxygen uptake, expressed as multiples of an assumed oxygen uptake (VO2) at rest of 3.5 mL/kg/min. Thus, a peak exercise capacity of 10 METs corresponds to an For the purpose of this study, in calculating the SBP/MET-slope (∆SBP/∆METs); ∆METs was calculated as [peak METs -1].
Selection of lower risk subjects
We defined a subgroup of patients with lower cardiovascular risk, by selecting subjects surviving at least 10 years and not fulfilling any of the following criteria: o Beta-blocker, anti-hypertensive, nitrates, anti-arrhythmics, diuretics, digoxin -<75% of age-predicted exercise capacity (in METs)
Selection of covariables in adjusted Cox proportional hazard models
We computed the following Cox proportional hazard models;
• Unadjusted In the calculation of adjusted HR based on continuous hemodynamic variables standardized as Z-scores, the additional adjusted models were used:
• Model 3a: also adjusted for SBP at rest (but not for peak METs)
• Model 3b: also adjusted for peak METs (but not for SBP at rest) Use anti-hypertensive medications and use of statins were incorporated in the definition of hypertension and hypercholesterolemia, respectively, and thus not included in the Cox proportional hazard models. MET, metabolic equivalent of task; SBP, systolic blood pressure; ΔSBP, increase in SBP from rest to peak exercise. MET, metabolic equivalent of task. values of SBP at rest or peak METs, respectively. Rate-pressure product calculated as peak heart rate multiplied by peak systolic blood pressure. Higher systolic blood pressure (SBP) at rest (left side) was associated with increased mortality over quartiles in unadjusted, but not in adjusted analysis. Higher fitness (peak METs, right hand side) was associated with lower mortality, and there was a statistically significant difference between all quartiles in adjusted analysis.
Supplementary Tables
The hazard ratios were adjusted for baseline age, test year, body mass index, comorbidities (stroke, claudication, previous coronary artery disease, atrial fibrillation and chronic obstructive pulmonary disease), risk factors (diabetes mellitus, smoking and hypercholesterolemia) and use of beta-blocker. Mortality increased with higher quartile of SBP/MET-slope in both groups, the overall survival was on average two years longer in subjects tested in the latter time period of the study inclusion. Using the median value of fitness (peak METs) and the median value of the SBP/MET-slope, four groups were constructed as illustrated in panel A. A higher SBP/MET-slope were associated with increased mortality in subjects with higher fitness but not in those with lower fitness (panel B and C).
Shaded area in panel B corresponds to 95% confidence interval for survival curve. Hazard ratios were adjusted for test year, age, body mass index, cardiovascular risk factors, medications and comorbidities as noted in methods. MET, metabolic equivalent of task; SBP, systolic blood pressure; ΔSBP and ΔMET, increase in SBP and MET from baseline
